Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Cerevance To Focus On Parkinson’s Adjunctive Therapy After Phase II Miss
Apr 01 2025
•
By
Joseph Haas
Cerevance takes a Phase II setback with its novel mechanism for Parkinson's disease
(Shutterstock)
More from Strategy
More from Therapy Areas